[Impact of guideline adherence on mortality in treatment of left heart failure]
- PMID: 26883900
- DOI: 10.1007/s00059-016-4401-0
[Impact of guideline adherence on mortality in treatment of left heart failure]
Abstract
Background: The German national guidelines on chronic heart failure provide treatment recommendations to physicians and reflect the current level of evidence; however, it is questionable to what extent these recommendations are applied in the routine practice and what the effect of guideline adherence on mortality is.
Methods: In this study the claims data of a major German health insurance fund collected over a period of 4 years were analyzed. Using binary logistic regression and Cox regression analyses the influence of drug prescriptions, diagnostic measures, influenza vaccination, the New York Heart Association (NYHA) status, the age and gender on mortality were examined.
Results: The study population consisted of 85,465 heart failure patients. Approximately 60 % of the drugs were prescribed according to the guidelines. There was a positive correlation between a higher NYHA status and mortality with an odds ratio (OR) of 3.264. Especially pharmacotherapy with angiotensin-converting enzyme (ACE) inhibitors and beta blockers according to the guidelines was associated with a lower mortality rate (OR 0.448 resp. 0.444). Also patients diagnosed using echocardiography at regular intervals showed a lower risk of dying (OR 0.314).
Conclusion: The results of this large sample could confirm the results of clinical trials that a therapy according to the guidelines has a significant impact on mortality. By analyzing the claims data evidence was found that in the treatment of heart failure patients the medical results could be improved by adherence to guideline recommendations.
Keywords: Claims data; Guideline adherence; Heart failure; Mortality; Pharmacotherapy.
Similar articles
-
Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.BMC Cardiovasc Disord. 2017 May 5;17(1):108. doi: 10.1186/s12872-017-0543-0. BMC Cardiovasc Disord. 2017. PMID: 28476146 Free PMC article.
-
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.Eur J Heart Fail. 2013 Oct;15(10):1173-84. doi: 10.1093/eurjhf/hft134. Epub 2013 Aug 26. Eur J Heart Fail. 2013. PMID: 23978433
-
Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.J Eval Clin Pract. 2008 Oct;14(5):823-9. doi: 10.1111/j.1365-2753.2008.01060.x. J Eval Clin Pract. 2008. PMID: 19018915 Clinical Trial.
-
[The new ESC Guidelines for acute and chronic heart failure 2016].Herz. 2016 Dec;41(8):655-663. doi: 10.1007/s00059-016-4496-3. Herz. 2016. PMID: 27858115 Review. German.
-
Comprehensive treatment of heart failure: state-of-the-art medical therapy.Rev Cardiovasc Med. 2005;6 Suppl 2:S43-57. Rev Cardiovasc Med. 2005. PMID: 15891702 Review.
Cited by
-
B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.Syst Rev. 2018 Jul 31;7(1):112. doi: 10.1186/s13643-018-0776-8. Syst Rev. 2018. PMID: 30064502 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous